- Home
- TLPH
TLPH
Talphera Inc.
as 04-18-2025 1:44pm EST
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | SAN MATEO |
| Market Cap: | N/A | IPO Year: | 2011 |
| Target Price: | $4.50 | AVG Volume (30 days): | 59.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.45 - $1.27 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 3581.10% |
Stock Insider Trading Activity of Talphera Inc. (TLPH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | TLPH | CHIEF EXECUTIVE OFFICER | Apr 2 '25 | Buy | $0.59 | 213,310 | $124,999.66 | 403,769 |
Latest Talphera Inc. News
TLPH Breaking Stock News: Dive into TLPH Ticker-Specific Updates for Smart Investing
Argus Research
15 days ago
Daily – Vickers Top Buyers & Sellers for 04/04/2025
GuruFocus.com
18 days ago
Talphera Inc (TLPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Insights
PR Newswire
19 days ago
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
PR Newswire
19 days ago
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
PR Newswire
24 days ago
Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
PR Newswire
3 months ago
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
PR Newswire
5 months ago
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Simply Wall St.
5 months ago
Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023)
Compare TLPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLPH Talphera Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.